93 related articles for article (PubMed ID: 22143855)
1. Do pharmaceutical score cards give us the answers we seek?
Moodie P; Metcalfe S; Poynton M
N Z Med J; 2011 Nov; 124(1346):69-74. PubMed ID: 22143855
[TBL] [Abstract][Full Text] [Related]
2. Response to PHARMAC on Access to new medicines in New Zealand compared to Australia.
Milne R; Wonder M
N Z Med J; 2011 Dec; 124(1347):91-3. PubMed ID: 22237576
[No Abstract] [Full Text] [Related]
3. Access to new medicines in New Zealand compared to Australia.
Wonder M; Milne R
N Z Med J; 2011 Nov; 124(1346):12-28. PubMed ID: 22143849
[TBL] [Abstract][Full Text] [Related]
4. Patient access to pharmaceuticals: an international comparison.
Cohen J; Faden L; Predaris S; Young B
Eur J Health Econ; 2007 Sep; 8(3):253-66. PubMed ID: 17279403
[TBL] [Abstract][Full Text] [Related]
5. Comparing patient access to pharmaceuticals in the UK and US.
Cohen J; Cairns C; Paquette C; Faden L
Appl Health Econ Health Policy; 2006; 5(3):177-87. PubMed ID: 17132032
[TBL] [Abstract][Full Text] [Related]
6. The subsidy of pharmaceuticals in Australia: processes and challenges.
Sansom L
Aust Health Rev; 2004 Nov; 28(2):194-205. PubMed ID: 15527399
[TBL] [Abstract][Full Text] [Related]
7. Exploring the implications of a fixed budget for new medicines: a study of reimbursement of new medicines in Australia and New Zealand.
Taylor C; Wonder M
Aust Health Rev; 2015 Sep; 39(4):455-461. PubMed ID: 25751688
[TBL] [Abstract][Full Text] [Related]
8. A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand.
Ragupathy R; Aaltonen K; Tordoff J; Norris P; Reith D
Pharmacoeconomics; 2012 Nov; 30(11):1051-65. PubMed ID: 22963187
[TBL] [Abstract][Full Text] [Related]
9. Are Australians able to access new medicines on the pharmaceutical benefits scheme in a more or less timely manner? An analysis of pharmaceutical benefits advisory committee recommendations, 1999-2003.
Wonder MJ; Neville AM; Parsons R
Value Health; 2006; 9(4):205-12. PubMed ID: 16903989
[TBL] [Abstract][Full Text] [Related]
10. How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New Zealand.
Gleeson D; Lopert R; Reid P
Health Policy; 2013 Oct; 112(3):227-33. PubMed ID: 23992756
[TBL] [Abstract][Full Text] [Related]
11. Provision of pharmaceuticals in Australian hospitals: equity of access?
Gallego G; Taylor SJ; Brien JA
Pharm World Sci; 2007 Apr; 29(2):47-50. PubMed ID: 17149650
[TBL] [Abstract][Full Text] [Related]
12. An Rx for reform: a Medicare prescription drug benefit.
Rak J
Health Matrix Clevel; 2002; 12(2):449-505. PubMed ID: 12430363
[No Abstract] [Full Text] [Related]
13. Patient assistance programs: information is not our enemy.
Choudhry NK; Lee JL; Agnew-Blais J; Corcoran C; Shrank WH
Health Aff (Millwood); 2009; 28(3):843-4. PubMed ID: 19414896
[No Abstract] [Full Text] [Related]
14. The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand.
Aaltonen K; Ragupathy R; Tordoff J; Reith D; Norris P
Value Health; 2010; 13(1):148-56. PubMed ID: 19744294
[TBL] [Abstract][Full Text] [Related]
15. Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom.
Morgan SG; McMahon M; Mitton C; Roughead E; Kirk R; Kanavos P; Menon D
Health Aff (Millwood); 2006; 25(2):337-47. PubMed ID: 16522575
[TBL] [Abstract][Full Text] [Related]
16. The rise and fall of national and North Carolina policies addressing medication access for older adults.
Altman HK
N C Med J; 1999; 60(4):198-202. PubMed ID: 10424115
[No Abstract] [Full Text] [Related]
17. Improving availability and affordability of plasma-derived medicines.
Cheraghali AM; Abolghasemi H
Biologicals; 2010 Jan; 38(1):81-6. PubMed ID: 20137973
[TBL] [Abstract][Full Text] [Related]
18. The Health Impact Fund: incentives for improving access to medicines.
Banerjee A; Hollis A; Pogge T
Lancet; 2010 Jan; 375(9709):166-9. PubMed ID: 20109894
[No Abstract] [Full Text] [Related]
19. Medicare drugs.
Poisal JA
Health Care Financ Rev; 2003; 25(2):1-5. PubMed ID: 15124373
[TBL] [Abstract][Full Text] [Related]
20. Seniors with chronic health conditions and prescription drugs: benefits, wealth, and health.
Saver BG; Doescher MP; Jackson JE; Fishman P
Value Health; 2004; 7(2):133-43. PubMed ID: 15164803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
